Denali Therapeutics Inc (DNLI)

Denali Therapeutics Inc (DNLI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3B; returns 1 day -1.3%, 1 week +4.5%, 1 year +15.9%.

Denali Therapeutics Inc. (DNLI) is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases,. Their core strategy revolves around their proprietary Transport Vehicle (TV) platform, which facilitates drug delivery across the blood-brain barrier. Denali's business model relies on strategic partnerships and advancing its pipeline.

Groups DNLI belongs to

• Biotechnology
• Neuroscience
• Neurological Disorders
• Healthcare
• Life Sciences
• CNS Disorders
• Alzheimer's Disease
• Clinical Stage Biotech
• Rare Diseases
• Clinical Stage

DNLI financial model: income statement, cash flow and balance sheet